Clinical trial
Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
NCT00431080
Study timeline
Study start (unknown)2004-08-01Date precision: month
Registry last updated2008-01-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
DocetaxelDRUG · verified · RxNorm: docetaxel
PaclitaxelDRUG · verified · RxNorm: paclitaxel
EpirubicinDRUG · verified · RxNorm: epirubicin
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
5-fluoruracilDRUG
Sponsors & collaborators
Hellenic Oncology Research Grouplead sponsor
University Hospital of Cretecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00431080 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.